LONDON, ONTARIO -- (MARKET WIRE) -- November 09, 2006 -- Stellar Pharmaceuticals Inc. (TSX VENTURE: SLX)(OTCBB: SLXCF) (“Stellar” or “the Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the third quarter ended September 30, 2006. All amounts in this press release are in Canadian dollars, have been rounded to the nearest thousand, and are the result of the use of U.S. generally accepted accounting principles.
